Founded Year

2016

Stage

Seed | Alive

Total Raised

$30K

Last Raised

$30K | 3 yrs ago

About Dr CADx

Dr CADx is a computer-aided diagnostic system to help doctors as well as patients in diagnosing medical images more accurately. The company uses neural networks to develop algorithms that can interpret medical images with an accuracy that is comparable or even exceeds that of radiologists at a much lower cost.

Dr CADx Headquarter Location

Zimbabwe

263 773 738 135

Dr CADx's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Dr CADx's Products & Differentiation

See Dr CADx's products and how their products differentiate from alternatives and competitors

  • Dr CADx CXR3

    Dr CADx CXR3 provides an AI powered analysis of chest X-rays enabling doctors to make accurate diagnoses. The product detects 3 abnormalities on chest X-rays (airspace opacity, mass or nodule, and pneumothorax) with an overall AUC of 87%.

    Differentiation

    Dr CADx offers the most optimal performance-cost benefit on the market. It delivers high accuracy and provides significant medical outcomes such as 5 - 15% diagnostic improvements, but at less than … 

Expert Collections containing Dr CADx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Dr CADx is included in 6 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,442 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,707 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

10,939 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

C

Clinical Encounter Tech

897 items

Latest Dr CADx News

Permanent acceleration, remote assistance, and no cohorts: Meet The Baobab Network

Sep 17, 2019

Permanent acceleration, remote assistance, and no cohorts: Meet The Baobab Network Last month, Ethiopian ed-tech startup Beblocky, Zimbabwean AI-based health platform Dr Cadx, Kenyan insurtech startup Kakbima, Nigerian payments platform GladePay, and Ghanaian digital bank Pennysmart secured US$25,000 each from The Baobab Network after participating in its accelerator programme. Not much new there, you may think. Yet this accelerator programme has no cohorts, no fixed location, and no end date. And it is different for every company that takes part. In short, The Baobab Network is doing its best to reinvent how acceleration works in the African tech space. Formed in 2016 and initially known as New Venture Africa , The Baobab Network began life running intensive, one-week consulting programmes for tech startups across Africa, bringing top talent from its global partner network to work on the ground with local founders. It has broadened its horizons since, after rebranding and raising funding , as it looks to provide additional support for founders, but never intended to build an accelerator programme. In fact, we actively tried to avoid doing so because of negative connotations with the accelerator model that we’d encountered across the continent,” head of ventures Richard Sears told Disrupt Africa. “We investigated a number of different models, including joint ventures or licensing deals to help startups internationalise their tech. Ultimately though, the biggest challenge facing founders we worked with was accessing early-stage capital, so that’s where we decided to focus our efforts.” Its first innovation was in doing away with a set duration for the programme. Once a start-up joins The Baobab Network, they are always a part of The Baobab Network. “The idea that a startup can graduate from a three, six or even 12-month programme, pitch at a demo day and raise a US$1 million or more seed round generally doesn’t fly in nascent tech ecosystems,” Sears explains. “Where our startups operate, it generally takes founders longer to get to the stage where they can attract this level of funding, and we wanted to ensure we supported them throughout this journey.” That’s not all. Rather than have startups relocate for any period of time, as per most programmes, The Baobab Network decided to let founders stay with their businesses, with programmes mainly remote and the accelerator’s team travelling to the startups rather than the other way round. “We really didn’t want to take founders away from their businesses for extended periods of time, and we wanted to ensure we could work with startups across the whole continent, so we also decided to make our accelerator largely remote,” said Sears. Finally, the feedback the company received from its consulting projects suggested their value was largely derived from their bespoke nature. “Every project we ran was different because it was tailored to the needs of a particular startup, at a particular time. As a result we also decided to do away with cohorts,” Sears said. “In fact, we even decided not to have a set accelerator programme at all. Instead, just as we did with our consulting projects, we decided to create a tailor-made accelerator programme for each individual startup we work with.” So, in summary – no set duration, non-residential, no cohorts, no set programme. Not much like an accelerator at all, really. “We had no preconceptions about what an accelerator should look like and we started from scratch when creating our programme. Our aim was to build something that adequately addressed the myriad needs of startups operating across totally different sectors, technologies, business models and geographies,” said Sears. How does it all work in practice? The Baobab Network’s programme always starts with a one-week consulting project, where a handful of expert consultants travel to where a startup is based to work with founders on their businesses and the challenges they are facing. “While the week is about getting as much done as possible – and it’s incredible just how much we can achieve in such a short space of time – it’s also a chance for us to build a relationship with founders, which is critical as our work with startups after this initial week is largely remote,” Sears said. After the project, The Baobab Network injects US$25,000 into startups in return for a 10 per cent equity stake, and assigns a “Baobab Venture Partner” to each startup. For 24 months, this Venture Partner will provide hands-on support to startups on a remote basis. “They are responsible for building out the bespoke acceleration programme for the business – they do so by working with founders to set milestones and identify challenges to the business, then by building a tailor-made programme around these to help overcome the challenges and achieve the milestones,” said Sears. “And they act as a primary point of contact for startups at The Baobab Network, responsible for leveraging the skills and experience of our wider team, our corporate partners and our investment network to accelerate businesses and help secure funding to unlock their next phase of growth.” “Funding to unlock the next phase of growth” is what The Baobab Network is all about. The aim of the programme is to help founders raise a seed round of US$1 million or over from institutional investors. “A great deal of  work involves preparing founders and their businesses for follow-on investment. For some startups this may only take a few months, for others it could be a few years. Our aim is to stay flexible and ensure we’re best meeting the needs of our founders as they evolve through the early phases of their startup’s growth,” Sears said. Over the last few years The Baobab Network has built out a strong investor network of family offices, foundations and funds looking to invest across the continent, while Sears said it has also invested in growing its own angel network of retail investors and high net worth individuals, which it will leverage to help bridge the funding gap founders face. Other kinds of support is offered as well, almost entirely focused on the business side. This support is quite broad, ranging from setting up a company in the right way, through achieving product-market fit, to fundraising. Sears said the company’s challenge is to customise this support and deliver it at the right time, ensuring everything it does is relevant and that it is not distracting its founders in any way. For The Baobab Network, corporate partners are key to this, and larger organisations are brought into the fold to engage with its startups in a number of different ways. “We have partners like Accenture and L’Oréal who send top talent from around the world to work on consulting projects with our start-ups. Partners like ?What If! Innovation provide support on the ground, but also offer branding, design and product development support on a remote basis,” said Sears. “Then partners like Standard Chartered, Johnson & Johnson, Sanofi and Engie are more interested in running pilots with startups and exploring partnership and strategic investment opportunities with them. We also have a range of partners – including AWS, Twilio, Segment and Stripe Atlas – who offer credits and discounts to help get startups up and running.” So what is next for The Baobab Network off the back of investing in its first five startups? Sears said it is about to finalise terms with another three companies, and is striving for more continental coverage. “We are proud to go into countries that are more challenging for international investors and to develop structures to help de-risk these investments for others,” he said. “Most of the work we have done with startups is to ensure they have strong foundations in place from which they can scale; this has involved a lot of work on positioning, messaging and unit economics. We have also had some real success across business development, one of our real strengths, even at this early stage. We’re now starting our first fundraising efforts with these businesses, who are looking to secure between US$150,000 and US$500,000 in pre-seed funding over the coming months.”

Dr CADx Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Dr CADx Rank

  • When was Dr CADx founded?

    Dr CADx was founded in 2016.

  • What is Dr CADx's latest funding round?

    Dr CADx's latest funding round is Seed.

  • How much did Dr CADx raise?

    Dr CADx raised a total of $30K.

  • Who are the investors of Dr CADx?

    Investors of Dr CADx include The Baobab Network and Seedstars World.

  • Who are Dr CADx's competitors?

    Competitors of Dr CADx include Lunit and 1 more.

  • What products does Dr CADx offer?

    Dr CADx's products include Dr CADx CXR3.

You May Also Like

Iterative Scopes Logo
Iterative Scopes

Iterative Scopes is a software-only gastrointestinal data company that is working to deliver AI toolkits to the practice of gastroenterology.

Ibex Medical Analytics Logo
Ibex Medical Analytics

Ibex Medical Analytics develops AI-driven clinical decision support tools that help pathologists deliver more efficient, metric-driven, objective and accurate diagnosis. Ibex develops a diagnostic system that uses computer vision, machine learning, and electronic medical records to confirm cancer diagnoses of tissue biopsies. The company was founded in 2016 and is based in Israel.

R
RadNet

RadNet is a national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. The company has a network of 293 owned and/or operated outpatient imaging centers.

Densitas Logo
Densitas

Densitas supports value-based care through advanced healthcare analytics powered by A.I. at the patient, clinic, and system levels. Its solutions provide on-demand insights for tailored risk-based management of patients and enable healthcare administrators to monitor clinical, quality, and operational performance indicators. The platform is uniquely designed to be fully PACS-centric by operating on the routinely archived standard DICOM images that radiologists review and supports point-of-care and retrospective processing of mammograms.

Cleerly Logo
Cleerly

Cleerly is a healthcare company that uses AI-powered imaging to analyze heart scans and whose mission is to create digital care pathways to prevent heart attacks. The company integrates clinical science with AI in order to offer clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, it aims to provide a comprehensive solution for cardiovascular disease evaluation that offers great value to the healthcare system and improves heart health for patients at risk of heart attacks. The company was founded in 2017 and is based in New York, New York.

S
Shukun Technology

Shukun Technology develops diagnostic systems by using machine learning and AI technology for hospitals to improve efficiency. The company focuses on cardiovascular diagnosis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.